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Edited by Ned ManteiAbstract The transcriptional repressor RE1 silencer transcrip-
tion factor (REST) is an important factor that restricts some
neuronal traits to neurons. Since these traits are also present in
pancreatic b-cells, we evaluated their role by generating a model
of insulin-secreting cells that express REST. The presence of
REST led to a decrease in expression of its known target genes,
whereas insulin expression and its cellular content were con-
served. As a consequence of REST expression, the capacity to
secrete insulin in response to mitochondrial fuels, a particularity
of mature b-cells, was impaired. These data provide evidence
that REST target genes are required for an appropriate glucose-
induced insulin secretion.
 2004 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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RE1 silencer transcription factor (REST), also named neu-
ron restrictive silencer factor (NRSF), is a nine-zinc ﬁnger
protein, which is widely expressed in all tissues with the ex-
ception of mature neuronal cells [1,2]. REST has been identi-
ﬁed as a transcriptional repressor that negatively regulates
expression of some speciﬁc neuronal genes in non-neuronal
cells and in neuronal precursor cells [3–6]. This transcription
factor binds to a cis repressor element of 23 bp termed RE1 or
neuron restrictive silencer element (NRSE) and recruits some
co-repressors such as mSIN3, coREST and histone deacety-
lases [7–10]. By this mechanism, a large number of genes are
directly repressed by REST [4,11–14]. Several studies, includ-
ing ours, have shown that some of these genes are also ex-
pressed in pancreatic b-cell lines where REST is absent [1,15].
These include islet-brain1/c-Jun N-terminal kinase interacting
protein-1 (IB1/JIP-1) [15], connexin36 [16] and complexin I
[17]. The aim of this study was to evaluate the role of REST
target genes in b-cell function. For this purpose, REST was
stably introduced in insulin-secreting cells. In these cells, ex-
pression of REST led to repression of its target genes. More-
over, these cells displayed an impairment of insulin secretion in* Corresponding author. Fax: +41-21-314-09-28.
E-mail address: gwaeber@chuv.hospvd.ch (G. Waeber).
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doi:10.1016/j.febslet.2004.04.002response to glucose and leucine, whereas the secretory re-
sponse to KCl was unchanged. This loss of function was
conﬁrmed by transient transfection of REST in diﬀerent in-
sulin-secreting cell lines. These data demonstrate that the
REST target genes are required for glucose-induced insulin
secretion.2. Materials and methods
2.1. Establishment of stable cell lines
The mouse pancreatic bTC3-cell line was cultured as previously
described [15]. Stable transfection was performed in 10-cm dishes using
45 ll of DOTAP solution (Roche Diagnostics) mixed with 7 lg of the
plasmid encoding the transcriptional repressor REST (RIP REST) [15]
and the plasmid encoding the hygromycin resistance cassette as se-
lection marker, in molecular ratio (10:1). Transfected cells were cul-
tured in the presence of 500 lg/ml hygromycin.
2.2. Total RNA preparation, Northern blot analysis, nuclear protein
extract preparation and electromobility shift assays (EMSA)
Nuclear extracts and EMSAs were performed as previously reported
[15,18]. Oligonucleotides used as labeled probes were as follows: NRSE
IB1 (forward: 50-GGCTTCAGCACCGCGGAGAGCGCCA-
TCTCC-30 and reverse: 50-CCGGAGATGGCGCTCTCCGCGGTG-
CTGAAG-30). Total RNA preparation and Northern blot analysis
were performed as described [15].
2.3. Measurement of insulin secretion and content
Cells (5 105) were plated in 48-well dishes for 48 h and were cul-
tured in 2 mM of glucose for 24 h. Cells were washed three times with a
modiﬁed Krebs–Ringer/bicarbonate–HEPES buﬀer, pH 7.4, as de-
scribed [19]. The cells were pre-incubated with this buﬀer containing 2
mM of glucose for 2 h at 37 C before incubation in KRBH containing
either 2 mM glucose (basal condition) or 20 mM of glucose (including
10 lM of forskolin and 100 lM of IBMX) or 20 mM leucine or 24 mM
KCl for 60 min. The supernatant was removed for the measurement of
secreted insulin and cells were extracted with acid/ethanol for insulin
content. These measurements were determined by radioimmunoassay
using rat insulin [20]. For exocytosis experiments, INS1 and bTC3 cells
(5 105) were seeded in 24-well plates and were transiently transfected
with 0.2 lg of the plasmid encoding the human growth hormone
(hGH) with the eﬀectene reagent (Qiagen) as previously described [17].
2.4. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) reduction assay
To measure the cellular metabolic rate, cells were plated and prein-
cubated in KRB for 60 min. After pre-incubation, the cells were re-
placed with KRB under stimulatory conditions containing 0.1 mg/ml
MTT (Sigma) for 30-min incubation. The supernatants were removed
and the insoluble MTT metabolite within the cell monolayer was ex-
tracted with the SDS–HCl solution (0.01 M HCl and 10% SDS). The
absorbance of the extractants at 570 nm was recorded using arbitrary
OD units.blished by Elsevier B.V. All rights reserved.
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3.1. Establishment of an insulinoma cell line expressing the
transcriptional repressor REST
Mouse insulin-secreting bTC3 cells were stably transfected
with a plasmid encoding REST under the control of the ratFig. 1. (A) Northern blot analysis of exogenous REST and b-actin mRNA
resistant clones transfected with RIP REST (R1 and R2) and two randomly se
REST cDNA probe as previously described [15]. The b-actin probe is used to
only in R1 and R2 but not in control C1 and C2 cells. (B) REST binding activ
of binding activity (a) was detected with R1 and R2 cells compared to free pr
was not competed by adding a 100- or 600-fold molar excess of unlabeled w
binding activity with IB1NRSE was disrupted in REST-expressing clones by u
NRSE was silenced in R1 and R2 clones. Heterologous promoter constructs
The wtNRSE led to a marked decrease in both R1 and R2 compared to the ba
of mutNRSE promoter. Luciferase activities were normalized using pRLS
triplicate. All values are expressed as percent of the SV40luc activity. Resu
REST target genes such as SCG10 and IB1/JIP-1 is decreased in R1/R2 clones
actin was performed as described [15]. The SCG10 and IB1/JIP-1 mRNA le
SCG10 mRNA levels decreased by 5- and 7-fold in R1 and R2 clones, resp
almost undetectable in R1 and R2.insulin promoter (or the empty vector as control). Hygromy-
cin-resistant clones were assessed for the expression of REST
by Northern blot analysis. Two resistant clones, R1 and R2
(R1/R2), were found to express the REST transcript unlike the
randomly selected C1 and C2 control clones (C1/C2) that do
not contain endogenous REST factor (Fig. 1A). The REST-in bTC3 cells. Total RNA (15 lg) was isolated from two hygromycin-
lected controls (C1 and C2). RNA was then hybridized with the human
evaluate the quantity of total RNA loaded. A transcript was detected
ity is detected in REST-expressing clones R1 and R2. A similar pattern
obe migration (b). The arrow c corresponds to an unspeciﬁc band that
ild type NRSE (data not shown). NE, nuclear extract. (C) This DNA-
sing REST antibodies. NE, nuclear extract. (D) The activity containing
were then transiently transfected into control C1/C2 and R1/R2 clones.
sal activity of the SV40luc. The mutation in NRSE restored the activity
V40 renilla. Each experiment was performed at least three times in
lts are expressed as meansS.E.M. (P < 0:001). (E) Expression of
. Northern blot of REST target genes such as SCG10, IB1/JIP-1 and b-
vels were measured by densitometric scanning. Normalized to b-actin,
ectively, compared to C1/C2 cells. The IB1/JIP-1 mRNA levels were
Fig. 2. Insulin expression and content of R1/R2 and C1/C2 cells. (A)
Northern blot analysis of mRNA levels for insulin and several im-
portant genes controlling insulin expression and secretion [PDX1,
Glut2, GK and HNF1a]. (B) Insulin content by radioimmunoassay.
Similar insulin mRNA levels and content were observed in R1/R2 and
C1/C2 cells. Data are meansS.E.M. of six independent experiments.
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from R1/R2 and C1/C2 control cells. The labeled probe used
was the NRSE previously identiﬁed within the IB1 promoter
[15]. The REST binding activity was detected in nuclear ex-
tracts prepared from R1/R2 but not from control cells
(Fig. 1B). This binding activity was disrupted by addition of a
REST antibody, indicating that the observed pattern is speciﬁc
to REST (Fig. 1C). The transcriptional repressive eﬀect of
REST in R1/R2 clones was functionally conﬁrmed by mea-
suring the activity of the luciferase reporter gene under the
control of NRSE. We used a construct containing two wild-
type (wtNRSE) or mutated NRSE motifs (mutNRSE) cloned
upstream of the SV40 promoter linked to the luciferase gene
reporter as previously described [15]. Since NRSE is a negative
element, its active form should reduce expression of the re-
porter. Control C1/C2 cells and R1/R2 cells were transiently
transfected with these diﬀerent constructs. In control cells,
luciferase activities of wtNRSE and mutNRSE constructs were
not diﬀerent from SV40luc (Fig. 1D). In contrast, in both R1/
R2 cells expressing REST, the activity of constructs containing
wtNRSE was reduced by 75% and 80% compared to SV40luc.
As expected, this activity was restored when the NRSE motif
was mutated, indicating that REST was unable to bind to the
mutated NRSE. As expected, the luciferase activity was like-
wise restored when R1/R2 cells were treated with trichostatin,
an inhibitor of histone deacetylase (data not shown). This re-
sult is consistent with previous reports showing that REST-
mediated transcriptional repression requires histone deacety-
lase activity [15]. The transcriptional eﬀect of REST on its
endogenous target genes was then investigated. IB1/JIP-1- and
SCG10-encoding genes, known to be negatively modulated by
REST, were then selected [7,15]. Expression of both IB1/JIP-1
and SCG10 in R1/R2 was virtually abolished compared to
control cells (Fig. 1E). Taken together, these data conﬁrm the
generation of an insulin-secreting cell model expressing the
functional transcriptional repressor REST.
3.2. Glucose-induced insulin secretion is impaired in
REST-expressing clones
We next evaluated expression and secretion of insulin in cells
stably expressing REST. R1/R2 cells and control C1/C2 cells
have similar levels of insulin mRNA and protein contents
(Fig. 2A and B). Northern blot analysis showed that mRNA
levels of several diabetogenic genes known to regulate insulin
expression and secretion in response to glucose, such as those
encoding glucokinase (GK), the glucose transporter Glut2, the
transcription factors PDX1 and HNF1a, were similar in R1/
R2 and C1/C2 cells (Fig. 2A). Consistent with this result,
computer-assisted searches failed to ﬁnd any NRSEs in the
genomic sequence of these genes. NRSEs were also not found
in other genes important for insulin secretion including those
encoding pyruvate kinase, Kir6.1 and transcription factors
such as HNF4a, Nkx6.1, Nkx2.2, Pax6 and Isl1, indicating
that they are not targets of REST. We next investigated the
impact of the presence of REST on secretagogue-induced in-
sulin secretion. In control cells, insulin secretion was increased
by about 3-fold in response to glucose, whereas in the REST-
expressing clones (R1/R2) glucose was unable to elicit the re-
lease of insulin (Fig. 3A). Leucine speciﬁcally activates the
mitochondrial metabolism and acts downstream of glycolysis;
Kþ depolarizes the b-cell membrane and triggers exocytosis
independently of mitochondrial metabolism. In control cells,leucine and KCl stimulated insulin secretion by about 3-fold
(Fig. 3B). In R1/R2 cells, direct stimulation of the secretory
machinery of R1/R2 cells following Kþ depolarization and
Ca2þ entry led to an increase in insulin release comparable to
that obtained in control cells. In contrast, leucine did not
stimulate insulin secretion. To conﬁrm that impaired insulin
secretion in response to glucose is not related to clonal selec-
tion, we measured secretagogue-induced secretion in two dif-
ferent insulin-secreting cell lines, bTC3 and INS1, in which we
transiently re-expressed REST. To monitor exocytosis of the
cells, we co-transfected the cells with a plasmid encoding hGH.
In insulin-secreting cells, hGH is targeted to secretory granules
and is co-released with insulin during the exocytotic event [19].
hGH release can therefore be used as a reporter to measure
secretion from transiently transfected cells. In the absence of
REST, glucose, leucine and Kþ elicited an increase of about 3-
fold of hGH release both in bTC3 and INS1 cells (Fig. 4A and
B). When REST was expressed, the secretory response to
glucose and leucine was either diminished (INS1 cells) or
abolished (bTC3 cells). However, in all cases KCl-induced
secretion was preserved. These data, together with the ﬁndings
obtained with stably transfected cell lines, demonstrate that the
exocytotic apparatus of REST-expressing cells is still func-
tional but the coupling of the secretory machinery to mito-
chondrial metabolism is missing.
Fig. 3. (A) Glucose-induced insulin secretion of R1/R2 and C1/C2 cells. Cells in (5 105) were seeded in 24-well plates, cultured for 48 h and pre-
incubated in KRBH buﬀer under basal condition (2 mM of glucose) for 60 min. Cells were incubated in the same buﬀer for 60 min in 2 mM (basal) or
20 mM of glucose plus 100 lM of IBMX and 10 lM of forskolin. The supernatant was recovered for insulin measurement. Results are expressed as a
percentage of insulin content. Control C1 and C2 cells were able to stimulate the secretion by 3-fold, whereas R1 and R2 cells did not stimulate
insulin secretion. (B) Insulin secretion in response to non-glucose secretagogue. C1 and C2 cells stimulated insulin secretion by 3-fold in response to
leucine and KCl. R1 and R2 cells did not stimulate insulin secretion in response to leucine, whereas the response to KCl was similar to control cells.
Results are expressed as means S.E.M. of four independent experiments in triplicate (P < 0:001).
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Glucose-stimulated insulin secretion requires glycolysis and
mitochondrial oxidation [21]. Leucine acts downstream of
glycolysis and depends exclusively on mitochondrial oxidation
for its signal generation [21]. The reduction of the tetrazolium
salt (MTT) is regarded as an indicator of cell redox activity,
which is attributed mainly to mitochondrial enzymes and
electron carriers. Therefore, the MTT reduction assay can be
used to evaluate the mitochondrial metabolic rate in b-cells
under stimulatory conditions such as glucose or leucine [22].
We performed the MTT reduction assay in R1/R2 and control
cells over a period of 30 min. R1/R2 and control C1/C2 cells
exhibited a similar increase of MTT reduction under glucose
and leucine stimulation, indicating that the REST-expressing
cells had a normal metabolic rate (Fig. 5).4. Discussion
The transcriptional repressor REST is not expressed in in-
sulin-secreting cell lines [1,15]. By reintroducing REST in in-
sulin-secreting cell lines, we found that expression of its known
target genes such as IB1/JIP-1 and SCG10 was repressed,
whereas insulin production was unchanged. Because the major
function of pancreatic b-cells is to secrete insulin in response to
glucose, we measured the capability of REST-expressing cells
to accomplish this task. In REST-expressing cells, basal insulinsecretion was unaﬀected whereas glucose-induced insulin se-
cretion was impaired. Similar results were obtained after
transient expression of REST in two diﬀerent insulin-secreting
bTC3 and INS1 cell lines, conﬁrming that the impaired insulin
secretion in response to glucose observed in R1/R2 cells ex-
pressing REST cannot be attributed to clonal selection. Since
leucine is an exclusive metabolic activator of mitochondria, the
loss of glucose- and leucine-induced insulin secretion could be
caused by a reduction of mitochondrial activity. However, the
MTT reduction in response to glucose and leucine was similar
in REST-expressing cells and control cells, suggesting a normal
cellular metabolic rate from mitochondria oxidation, which
may reﬂect a normal ATP production. In principle, the se-
cretory defect observed in REST-expressing cells could result
from a defective coupling between glucose metabolism and
insulin exocytosis and/or from a generalized impairment in the
process of insulin exocytosis. The former hypothesis appears
very unlikely because the secretory response of REST-ex-
pressing cells to depolarizing Kþ concentrations, which trig-
gers insulin release independently from mitochondrial
metabolism, was unaﬀected. In this report, we show that the
loss of insulin secretion is not associated with any change in
the expression of genes known to control insulin production
and secretion. Consistent with this observation, these genes
were not identiﬁed as targets of REST. The impairment of
glucose-induced insulin secretion is most probably the result of
alterations aﬀecting multiple REST target genes. A battery
Fig. 4. Eﬀects of transient expression of REST on secretagogue-in-
duced secretion in insulin-secreting bTC3 and INS1 cells. (A) bTC3
and (B) INS1 cells were transiently co-transfected with a plasmid en-
coding hGH as a reporter gene for secretion and with the REST ex-
pression vector (under the control of the rat insulin promoter RIP,
+REST) or the empty RIP vector as control ()REST). The ﬁgure
shows meansS.E.M. of at least three independent experiments
measured in triplicate (P < 0:01, P < 0:001).
Fig. 5. MTT reduction assays. Control C1/C2 and R1/R2 cells were
cultured in a 24-well plate for 2 days and pre-incubated for 60 min in
KRBH buﬀer under basal condition. Cells were then incubated for 60
min under basal condition or stimulatory conditions (glucose, leucine
and KCl) in the presence of MTT. Numbers are means S.E.M. of
four independent experiments in triplicate (P < 0:01, P < 0:001).
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in b-cells [1,15–17]. Computer-assisted searches for NRSE in
the whole genomic sequence predict the existence of a large
number of additional putative REST target genes that have so
far not been experimentally validated [23]. Any of these genes
might also be expressed in insulin-secreting cells and be nec-
essary for the secretory phenotype of b-cells.
In the future, detailed analysis of the gene pattern in our b-
cell model expressing REST will be very useful for the identi-
ﬁcation of all these genes. In view of the phenotype observed in
b-cells expressing REST, the functional characterization of its
target genes will contribute to clarify the mechanisms coupling
glucose metabolism to insulin secretion. In this report, we
demonstrate that REST target genes are necessary for glucose-
induced insulin secretion. As a consequence, a loss of function
or a decrease of expression of its target genes could lead to
impaired glucose-induced insulin secretion and potentially to
diabetes. In support of this, a mutation in the human MAP-
K8IP1 gene was already found to be associated with a rare and
monogenic form of type 2 diabetes in a French diabetic family
[18]. Type 1 diabetes results from an autoimmune attack that
may be directed at molecular targets speciﬁcally expressed by
b-cells and neurons, such as the autoantigen (ICA) 512, a re-
ceptor tyrosine phosphatase-like protein [24]. Thus, the iden-
tiﬁcation of additional REST target genes will highlightnew candidate genes potentially involved in both forms of
diabetes.
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